We are currently upgrading our website. Please bear with us if you are experiencing any loading issues.

Be Part of the Asia Pacific MedTech Forum 2024

Value Assessment of Innovative Medical Technology under DRG Reform

Value Assessment of Innovative Medical Technology under DRG Reform

APACMed China launched the DRG-based value assessment project in 2021 to identify key challenges faced by innovative medical technologies in the ongoing DRG reform of China. APACMed China set up a DRG working group to follow up with key policymakers, KoLs and HCPs in China to develop the first industry research report.

The report, in Chinese, provides an overview of the current landscape, its challenges, as well as key recommendations going forward. An abridged English report is also available.

Share This Post

Keep up with our MedTech Events

View our full listing of events and join us.

APF00347
Shopping Basket